NASDAQ:AZYO • US05479K1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AZIYO BIOLOGICS INC-CLASS A (AZYO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-12 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2022-11-16 | Truist Securities | Maintains | Buy |
| 2022-11-15 | Piper Sandler | Maintains | Overweight |
| 2022-03-04 | Cowen & Co. | Maintains | Outperform |
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 42.68M -0.51% | 47.39M 11.04% | 49.187M 3.79% | 43.554M -11.45% | 52.326M 20.14% | |
| EBITDA YoY % growth | -9.74M -114.07% | -19.302M -98.17% | -22.807M -18.16% | -23.971M -5.10% | -18.954M 20.93% | |
| EBIT YoY % growth | -13.6M -61.71% | -23.032M -69.35% | -26.54M -15.23% | -14.688M 44.66% | -17.748M -20.83% | |
| Operating Margin | -31.87% | -48.60% | -53.96% | -33.72% | -33.92% | |
| EPS YoY % growth | N/A | -2.71 55.29% | -2.40 11.44% | -2.17 9.47% | -1.46 32.86% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.57 21.75% | -0.45 -18.11% | -0.43 11.32% | -0.49 24.36% | -0.47 17.32% | -0.48 -7.27% |
| Revenue Q2Q % growth | 9.69M -21.79% | 10.098M -20.27% | 13.626M 4.41% | 16.787M 63.04% | 17.073M 76.19% | 18.568M 83.88% |
| EBITDA Q2Q % growth | -6.185M -75.57% | -6.167M -239.21% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.65M -21.06% | -6.63M -19.44% | -6.609M -46.63% | -7.806M 0.10% | -7.46M 2.48% | -7.706M -16.23% |
All data in USD
7 analysts have analysed AZYO and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49.
AZIYO BIOLOGICS INC-CLASS A (AZYO) will report earnings on 2023-11-13, after the market close.
The consensus EPS estimate for the next earnings of AZIYO BIOLOGICS INC-CLASS A (AZYO) is -0.57 USD and the consensus revenue estimate is 9.69M USD.